FDA Clearance Tracker · P150031-S055
Vercise S8 Adapter
Last checked: Nov 20, 2026Latest source record: Sep 6, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 6, 2023
Approved
Time to decision
173 days
Received Mar 17, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150031-S055
- Device name
- Vercise S8 Adapter
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Mar 17, 2023
- Decided
- Sep 6, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150031
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Vercise Adapter S8 and the addition of the use with Abbott Lead models (6170, 6171, 6172, 6173, 6178, 6179, 6180, and 6181) to the Vercise Neural Navigator 5 (VNN5) software.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.